Radicut oral suspension 2.1%, manufactured by Mitsubishi Tanabe Pharma, contains Edaravone and is used to inhibit the progression of functional disorders in patients with amyotrophic lateral sclerosis (ALS). It has a YJ code of 1190032S1021 and a standard of 2.1% 1mL.
Radicut oral suspension 2.1%
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).